Edgar Snyder & Associates®
A Law Firm Representing Injured People
1-866-943-3427
Call Us Toll Free 24/7

July 2007 Archive

Published on Jul 31, 2007 by Edgar Snyder
Accutane

The iPLEDGE program, guided by the Food and Drug Administration to prevent birth defects in the unborn children of women taking the acne drug Isotretinoin, has nearly no affect in stopping pregnancies. The past year has seen 122 women become pregnant while registered with iPLEDGE, about the same number of pregnancies reported before the program became mandatory last year.

Published on Jul 27, 2007 by Edgar Snyder
Zelnorm

The dangerous drug Zelnorm has been allowed to return to market for restricted use by women less than 55 years of age suffering from irritable bowel syndrome (IBS) with constipation and chronic idiopathic constipation. The Food and Drug Administration (FDA) has permitted limited prescriptions of Zelnorm under their investigational new drug (IND) protocol, often used for serious or life threatening conditions.

Published on Jul 12, 2007 by Edgar Snyder
Diabetes Risk Raised by Selenium

Researchers have found that taking supplements of Selenium – a mineral often believed to decrease diabetes risk – may actually increase the chance of contracting the disease. Results show that selenium supplements are linked to a 50 percent greater risk of getting diabetes.

Published on Jul 11, 2007 by Edgar Snyder
Injection Drug

The Food and Drug Administration (FDA) has alerted consumers about two injection solution drugs with potentially heightened risks. Rocephin, an antibiotic injection drug, has updated its label with important information about dangerous side effects. Invanz, another antibiotic, has three tainted lots that have been recalled by its manufacturer.

Published on Jul 09, 2007 by Edgar Snyder
vioxx

A soon to be published study by Oxford University has found that Vioxx, a dangerous painkiller pulled from the market in 2004, may have caused heart attacks and strokes much sooner than originally believed. Researchers dispute previous claims by finding that half the cardiovascular events linked to Vioxx in the study occurred within the first 12 months of the drug’s use.

Free Case Review
First Name
Last Name
ZIP
Phone
Email
Briefly describe your injuries